clinical trial · NCT07365826
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age
Pneumococcal Vaccines31-valent pneumococcal conjugate vaccineSeasonal Influenza Vaccine (SIV) (Flublok)Placebo
brief summary
This is a Phase 3, randomized, double-blind study to evaluate the safety and immunogenicity of VAX-31 and seasonal influenza vaccine in pneumococcal-naïve adults ≥ 50 years when the two vaccines are administered at the same visit or separately.
started
Jan 12, 2026
primary completion
Mar 1, 2027
completion
Mar 1, 2027
last updated
Jun 30, 2026
official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 Concomitantly Administered With Seasonal Influenza Vaccine in Healthy Subjects 50 Years of Age and Older
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol